These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1047448)

  • 21. [Family studies in hyperlipoproteinemia type I].
    Ditschuneit H; Bremer HJ; Eckart M; Faulhaber JD; Hiller G; Klör U; Rakow AD; Thun HJ
    Verh Dtsch Ges Inn Med; 1972; 78():1339-42. PubMed ID: 4665539
    [No Abstract]   [Full Text] [Related]  

  • 22. Type I hyperlipoproteinemia.
    Maldonado N; Frías AE; Cancio M; Gulbrandsen C; Haddock J
    Bol Asoc Med P R; 1970 Nov; 62(11):301-5. PubMed ID: 5278395
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical observations on 218 cases of primary hyperlipoproteinemia].
    Romics L; Szigeti A; Varsányi-Nagy M; Gerö S
    Orv Hetil; 1975 Oct; 116(43):2527-31. PubMed ID: 1187131
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pancreatitis in idiopathic hyperlipidemias. Personal series of 40 cases].
    de Gennes JL; Turpin G; Truffert J
    Ann Med Interne (Paris); 1974 Apr; 125(4):333-46. PubMed ID: 4433096
    [No Abstract]   [Full Text] [Related]  

  • 25. A scheme for the treatment of hyperlipidemia.
    Spencer JM; Hutchinson RG; Hill JE
    J Miss State Med Assoc; 1990 Apr; 31(4):111-6. PubMed ID: 2332888
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hyperlipemia in children].
    Ose L
    Tidsskr Nor Laegeforen; 1977 Jan; 97(2):67-73. PubMed ID: 835105
    [No Abstract]   [Full Text] [Related]  

  • 27. The Muscatine hyperlipidemia family study program.
    Schrott HG; Bucher KA; Clarke WR; Lauer RM
    Prog Clin Biol Res; 1979; 32():619-46. PubMed ID: 523488
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hyperlipoproteinemias in childhood].
    Czerny B
    Kinderarztl Prax; 1978 Nov; 46(11):561-9. PubMed ID: 366234
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hypercholesterolemia and the diagnosis and management of hyper- lipidemia in adults. Recommendations of the working groups of the Finnish Society of Internal Medicine and the Finnish Cardiology Society].
    Duodecim; 1988; 104(18):1425-38. PubMed ID: 3181045
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperlipoproteinemia survey.
    Pribor HC
    J Med Soc N J; 1973 May; 70(5):399-402. PubMed ID: 4512400
    [No Abstract]   [Full Text] [Related]  

  • 32. [Additions to the consensus policy in the diagnosis and treatment of hyperlipidemia in clinical practice].
    de Bruin TW; Wolffenbuttel BH; Bonnier JJ; Gevers Leuven JA; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2227-30. PubMed ID: 8984367
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 34. [Classification of hyperlipoproteinemia. II. Distribution principle of hyperlipoproteinemias according to Fredrickson et al. correlated with clinical dermatological possibilities].
    Zabel R
    Dermatol Monatsschr; 1973 Dec; 159(12):1137-43. PubMed ID: 4366868
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of dyslipidemia in adults.
    Ahmed SM; Clasen ME; Donnelly JE
    Am Fam Physician; 1998 May; 57(9):2192-2204, 2207-8. PubMed ID: 9606309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exocrine pancreatic insufficiency with familial hyperlipoproteinemia. Pancreatitis-hyperlipoproteinemia problems].
    Löffler A; Filippini L; Pulver W
    Schweiz Med Wochenschr; 1971 May; 101(18):634-7. PubMed ID: 5577379
    [No Abstract]   [Full Text] [Related]  

  • 37. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
    Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B
    An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mixed hyperlipemia with a distinct accumulation of beta and prebeta lipoproteins (apropos of 78 cases)].
    Loeper J; Rouffy J; Loeper J
    Arch Mal Coeur Vaiss; 1970-1971; 12():Suppl 1:3-15. PubMed ID: 5004789
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
    Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.